| Manufacturer ▼ | Drug Name | Indication | Stage | Status | Route of Administration | Drug Class |
|---|---|---|---|---|---|---|
| Scilex Holding Company | KDS2010 | Obesity | Phase 2 | Ongoing | Oral | Endocrinology |
| Scilex Holding Company | SP-104 | Fibromyalgia | Phase 2 | Oral | Neurology | |
| Scilex Holding Company | SP-103 | Acute lower back pain (LBP) | Phase 2 | Transdermal | Orthopedic | |
| Scinai Immunotherapeutics Ltd. | M-001 | Universal flu vaccine | Phase 3 | Intramuscular | Immunology | |
| Scinai Immunotherapeutics Ltd. | M-001 | Universal flu vaccine | Phase 2 | Intramuscular | Immunology | |
| SciSparc Ltd. | SCI-110 | Alzheimer Disease and Agitation | Phase 2a | Data Released | Oral | Neurology |
| SCYNEXIS Inc. | SCY-078 (oral) - (CARES) | Candida Auris | Phase 3 | Trial Completed | oral | Anti-Fungal |
| SCYNEXIS Inc. | BREXAFEMME (ibrexafungerp) - (FURI) | Invasive candidiasis | Phase 3 | Trial Completed | Oral | Anti-Fungal |